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http://dx.doi.org/10.1016/j.jmii.2015
1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Human coronavirus (HCoV) NL63 is recognized in association
with upper or lower respiratory tract illnesses in children. This study surveyed the prevalence
of HCoV-NL63 and influenza viruses in patients with influenza-like illness in Taiwan during 2010
e2011.
Methods: Throat samples from 107 hospitalized patients with pneumonia and 175 outpatients
with influenza-like illness were examined using real-time polymerase chain reaction assays
with virus-specific primers, and then virus-positive specimens were confirmed by sequencing
the polymerase chain reaction products.
Results: HCoV-NL63 infection was identified in 8.4% (9/107) of hospitalized patients with pneu-
monia, but not found in outpatients with influenza-like illness. Age distribution of HCoV-NL63
infection in hospitalized patients with pneumonia indicated that the group aged 16e25 years
(20%) had the highest positive rate compared with the other groups, and exhibited a similar
age-specific pattern to influenza A/H1N1 infection, but not influenza A/H3N2 and B infections
in hospitalized patients. Seasonal prevalence of HCoV-NL63 infection was late winter, overlap-
ping the highest peak of the influenza A/H1N1 epidemic during December 2010 to March 2011of Medical Laboratory Science and Biotechnology, China Medical University, Number 91, Hsueh-Shih
du.tw (C.-W. Lin).
ang S-H, et al., Epidemiology of human coronavirus NL63 infection among hospitalized patients with
robiology, Immunology and Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.10.008
.10.008
Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
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pneumonia in Taiwan, Journal of Micin Taiwan. Co-infection of HCoV-NL63 and influenza A/H1N1 was detected in three hospitalized
patients. Clinical manifestation analysis indicated that the main symptoms for HCoV-NL63
infection included fever (88.9%), cough (77.8%), and pneumonia (100%). Co-infection caused
significantly higher rates of breathing difficulties, cough, and sore throat than those of single
infection with HCoV-NL63 and influenza A/H1N1. Phylogenetic analysis indicated a low level of
heterogeneity between Taiwan and global HCoV-NL63 strains.
Conclusion: Understanding epidemiology of HCoV-NL63 in Taiwan provides an insight for world-
wide surveillance of HCoV-NL63 infection.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Human coronavirus (HCoV) NL63 was identified from the
nasopharyngeal aspirate specimen of a 7-month-old child
with coryza, conjunctivitis, fever, and bronchiolitis in
2004, as a member of the Coronaviridae family, like HCoV-
229E, HCoV-OC43, severe acute respiratory syndrome CoV,
HCoV-HKU1, and Middle East respiratory syndrome CoV.1,2
CoV genome is a near 30-kb positive-strand RNA with a 50
cap and 30 poly (A) tract that contains 14 open reading
frames (ORFs) encoding for nonstructural proteins and
structural proteins [conserved spike (S), envelope (E),
membrane (M), and nucleocapsid].1,2 The 50 proximal and
largest of these ORFs encodes two large overlapping pol-
yproteins replicase 1a and 1ab (w450 kDa and w750 kDa,
respectively) processed to produce nonstructural proteins
(nsps) primarily involved in RNA replication. Two specific
embedded proteases, papain-like (PLpro) and 3C-like
(3CLpro), mediate processing of 1a and 1ab precursors into
16 nsps (termed nsp1ensp16). Phylogenetic tree analysis
of CoV genomes indicates HCoV-NL63 forming a subcluster
with HCoV-229E, porcine epidemic diarrhea virus, and Bat-
CoV, assigned to the alphacoronaviruses.3 Among all
genes, HCoV-NL63 nucleocapsid (N) shows a low percent-
age of nucleotide and amino acid identity compared to
other CoVs.2
HCoV-NL63 infection is usually surveyed in children with
upper or lower respiratory tract illnesses. HCoV-NL63
infection is found worldwide, but is rarely positive by
reverse transcriptase polymerase chain reaction (RT-PCR)
assays.4e7 The positive rate of HCoV-NL63 infection in
children ranges from 1.2% in Japan,7 1.3% in Taiwan,8 2.1%
in Australia,4 2.3% in Belgium,9 2.5% in Canada,10 to 7% in
Switzerland.11 For adults, HCoV-NL63 infection is identified
in 9.3% of respiratory tract illness patients under the age of
20 years in France.12 HCoV-NL63 infection is predominant in
the winter season in Australia, Belgium, Canada, France,
Germany and Japan,4,6,9,10,12,13 but in spring and summer in
Hong Kong,5 and in autumn and winter in Taiwan.8 This
study analyzed 2010e2011 surveillance data for HCoV-NL63
and influenza virus infection in hospitalized patients with
pneumonia and outpatients with influenza-like illness in
Taiwan, indicating the prevalence and phylogenetic anal-
ysis of HCoV-NL63 infection. Our results demonstrate a
comprehensive comparison between HCoV-NL63 andang S-H, et al., Epidemiology of h
robiology, Immunology and Infecinfluenza virus infection in hospitalized patients and
outpatients.
Methods
Study design
The study recruited 107 hospitalized patients with pneu-
monia and 175 outpatients with influenza-like symptoms in
China Medical University Hospital (Taichung, Taiwan) during
2010e2011. One throat swab was taken from each indi-
cated patient, and then examined using RT-PCR and real-
time RT-PCR for detection of HCoV-NL63, influenza viruses
A/H1N1, A/H3N2, and B. We followed guidelines estab-
lished by the China Medical University Hospital Institutional
Review Board (Taichung, Taiwan).
RT-PCR, real-time RT-PCR and sequencing
Human coronavirus NL63 provided by Dr. Lia van der Hoek
(Academic Medical Center, University of Amsterdam, Mei-
bergdreef, Amsterdam, TheNetherlands) propagated in LLC-
MK2 cells that grow in Modified Eagle’s Medium supple-
mented with 2 mM L-glutamine, 50 mg/mL penicillin, 50 mg/
mL streptomycin, 100 mg/mL neomycin, and 10% fetal bovine
serum. A QIAamp Virus RNA Mini Kit (Qiagen, Hilden, Ger-
many) was used to extract viral RNA from clinical samples
and supernatant of infected cells with HCoV-NL63, with
influenza A and B viruses as the positive controls. For
detection of HCoV-NL63 infection, a two-step RT-PCR using
SYBR Green I was used. The specific primer pair for HCoV-
NL63 N gene (nucleotides 26,416e26,666) was forward
primer 50-CTGATGGTGTTGTTTGGGTTGC-30 and reverse
primer 50-AGAATCAGAACGAGTGCGAGAC-30. Real-time RT-
PCR mixture contained 2.5 mL cDNA (reverse transcription
mixture), 200nM each primer in SYBR Green I master mix
(LightCycler TaqMAn Master; Roche Diagnostics, Indian-
apolis, Indiana, United States). PCR was performed with
amplification protocol consisting of one cycle at 50C for
2minutes, one cycle at 95C for 10minutes, 45 cycles at 95C
for 15 seconds, and 60C for 1 minute. Amplification and
detection of specific products were conducted in ABI PRISM
7700 sequence detection system (PE Applied Biosystems,
Foster City, California, United States). For typing ofuman coronavirus NL63 infection among hospitalized patients with
tion (2015), http://dx.doi.org/10.1016/j.jmii.2015.10.008
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RT-PCR and real-time RT-PCR assays were performed, as
described previously.14
Phylogenetic analysis
To confirm the real-time RT-PCR assays, the products of
nested RT-PCR for HCoV-NL63 1a gene were further
sequenced. The primers for nested RT-PCR were 50-
CTTTTGATAACGGTCACTATG-3’ (SS 5852-5P) and 50-CTCAT-
TACATAAAACATCAAA CGG-30 (P4G1M-5-3P) in the first PCR;
and 50-GGTCACTATGTAGTTTATGATG-30 (P3E2-5P) and 50-
GGATTTTTCATAACCACTTAC-30 (SS 6375-3P; coordinate
6313) in the nested PCR, as described previously.15 Nucle-
otide sequences of 1a gene from the product of nested RT-
PCR were sequenced and used for phylogenetic tree anal-
ysis. Reference sequences were chosen from GenBank
(www.ncbi.nlm.nih.gov/genbank). Genotypes and geno-
typic relationships for HCoV-NL63 1a genes were identified
by BioEdit 7.0.8 program (North Carolina State University at
Raleigh, NC, USA, http://www.mbio.ncsu.edu/BioEdit/
bioedit.html) to align sequences with reference se-
quences. Resulting datasets constructed phylogenetic trees
for HCoV-NL63 1a genes, using MEGA version 5.2 software
(http://www.megasoftware.net/). After maximum-
likelihood phylogenetic analyses in 1000 bootstrap repli-
cates, branch bootstrap values > 60% or p values < 0.05
clustering with specific genotype strains were determined.
Cluster robustness could not all be statistically rated at 75%
bootstrap due to the large size and high genetic similarity
of the data sets, thus, we used 60% to identify epidemic
clusters. For further support of lower bootstrap values in
cluster node, the maximum likelihood (ML) tree confirmed
statistical significance (p < 0.05) in each cluster node.Table 1 Clinical data of hospitalized patients with pneumonia
Hospita
Negativea HCoV NL63
positive
Flu A/H1N
positive
Cases 70 9 17
Average age (y) 37.3 41.7 42.4
Clinical symptom (%)
Breathing difficulties 48.6 55.6 52.9
Cough 60.0 77.8 82.4
Fever 88.6 88.9 82.4
Pneumonia
(chest X-ray)
100.0 100.00 100.0
Myalgia 20.0 44.4 41.2
Sore throat 2.9 11.1 11.8
Vomiting 0.0 0.0 0.0
Muscle spasm 0.0 0.0 0.0
Herpes angina 0.0 0.0 0.0
Headache 4.3 0.0 0.0
Encephalitis 0.0 0.0 0.0
a Negative for real-time reverse transcriptase polymerase chain re
H3N2, and influenza B viruses.
b Patients co-infected with HCoV NL63 and influenza A/H1N1.
c p Z 0.037 (negative or Flu A/H1N1 positive vs. co-infection).
d p < 0.02 (negative, HCoV NL63 positive or Flu A/H1N1 positive vs.
Flu Z influenza; HCoV Z human coronavirus.
Please cite this article in press as: Huang S-H, et al., Epidemiology of h
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SPSS version 12.0 software, two-tailed test, c2 test, and
Fisher’s exact test were used to analyze all data. Statis-
tical significance between both groups was noted at
p < 0.05.Results
Sensitivity of two-step real-time RT-PCR with SYBR
Green I
To examine the sensitivity and specificity of HCoV-NL63
detection, viral genomes were extracted from 200 mL
diluted supernatant containing 10e1000 pfu/mL HCoV-
NL63, and then quantitated using two-step real-time RT-
PCR assays. The Ct values were 30 for two copies, 27 for 20
copies, and 24 for 200 copies of HCoV-NL63. Melting curve
analysis revealed HCoV-NL63 N-specific amplicon melting at
81C. The PCR products were separated using 2% agarose
gel electrophoresis, where a 251-bp band was clearly
observed in the PCRs with 20 copies and 200 copies of HCoV-
NL63 post gels stained with ethidium bromide. The results
indicated that the detection limit of the two-step real-time
RT-PCR assay was around 20 copies of HCoV-NL63. In addi-
tion, cultured supernatants of coxsackie virus 16, entero-
virus 71, and influenza viruses were not detectable using
two-step real-time RT-PCR assay with HCoV N-specific
primers. Therefore, the two-step real-time RT-PCR assay
with HCoV N-specific primers had high sensitivity and
specificity, as applicable for high-throughput detection of
HCoV-NL63 infection.in this study
lized patients with pneumonia
1 Flu A/H3N2
positive
Flu B
positive
HCoV NL63
positive/Flu A/H1N1 positiveb
9 5 3
56.1 45.6 58.7
33.3 60.0 66.7c
88.9 100.0 100d
77.8 80.0 66.7
100.0 100.0 100
11.1 20.0 33.3
22.2 20.0 33.3d
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
action detection of HCoV NL63, influenza A/H1N1, influenza A/
co-infection).
uman coronavirus NL63 infection among hospitalized patients with
ion (2015), http://dx.doi.org/10.1016/j.jmii.2015.10.008
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A total of 282 throat swabs were taken from 107 hospitalized
patients and 175 outpatients at the University Hospital in
Central Taiwan from April 2010 to December 2011. All swabs
were screened, using rapid diagnostic tests to detect HCoV-
NL63 and influenza A/H1N1, A/H3N2, and B viruses. In hos-
pitalized patients, positive rates of real-time RT-PCR
detection were 8.4% (9/107) for HCoV-NL63, 15.9% (17/107)
for influenzaA/H1N1, 8.4% (9/107) for influenzaA/H3N2, and
4.7% (5/107) for influenzaB (Table 1, Figure 1A). Importantly,
co-infection of HCoV-NL63 and influenza A/H1N1 was iden-
tified in three hospitalized patients. However, HCoV-NL63
infection was not found in outpatients with influenza-like
illness (Table 2, Figure 1B). Lower positive rates of influ-
enza A/H1N1 (13.1%), A/H3N2 (2.9%), and B (0.6%) were
discovered in outpatients. Age distribution of HCoV-NL630
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Figure 1. Age distribution of human coronavirus NL63 (A, B) an
pneumonia (A, C) and outpatients with influenza-like illness (B, D)
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Interestingly, the prevalence of HCoV-NL63 was the second
highest among adults aged 76e85 years (1/7, 14.7%), and the
highest among young people aged 16e25 years (1/5, 20.0%;
Figure 1A). In contrast to HCoV-NL63, the positive rates in
hospitalized patients were the highest among adults aged
66e75 years (3/10, 30.0%), and the lowest among groups
aged < 5 years (0/16, 0%) for influenza A/H3N2 infection, as
well as the highest among adults aged 36e45 years (4/14,
28.6%), second highest among adults aged 56e65 years (3/
13, 23.1%), and lowest among the group aged 16e25 years (0/
14, 0%) for influenza A/H1N1 infection (Figure 1C). In addi-
tion, positive rates of influenza A/H1N1 in outpatients
ranked the highest among adults aged 26e35 years (1/5,
20.0%), second highest among children aged 2e5 years (17/
92, 18.5%), and lowest among the group aged > 36 years (0/
18, 0%; Figure 1D). Results indicated that age-specific0
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B-positive cases had different patterns.
Seasonality of HCoV-NL63 infection in Taiwan
HCoV-NL63 infection was identified in late winter in Taiwan
between January 2011 and February 2011 (Figure 2A). In
contrast to HCoV-NL63, influenza A/H3N2 infection was
predominant between August 2010 and December 2010,
whereas a positive rate of influenza A/H1N1 proved second
highest in November 2010 and highest in January 2011, and
declined after February 2011 (Figure 2B and C). No signifi-
cant difference between hospitalized patients and out-
patients was observed in the seasonality of influenza A/
H1N1 and A/H3N2. The results revealed that seasonality of
HCoV-NL63 infection overlapped the periods of influenza A/
H1N1 circulation in Taiwan. Importantly, co-infection of
HCoV-NL63 and influenza A/H1N1 appeared in three hospi-
talized patients >40 years of age in February 2011.
Clinical association of HCoV-NL63 infection
Patients were divided into six groups including negative,
HCoV-NL63 positive, influenza A/H1N1 positive, influenza
A/H3N2 positive, influenza B positive, and co-infection. The
clinical data of each group among hospitalized patient and
outpatients are shown in Tables 1 and 2. Among hospital-
ized patients, the average age (41.7 years) of the HCoV-
NL63 positive group was higher than the negative group,
but lower than the influenza A/H1N1 positive and influenza
B positive groups. Clinical symptoms of the HCoV-NL63
positive group were breathing difficulties (55.6%), cough
(77.8%), fever (88.9%), pneumonia (100%), myalgiaTable 2 Clinical data of the outpatients with influenza-like illn
Outpati
Negativea HCoV NL63
positive
Flu A/H1N
positive
Cases 146 0 23
Average age (y) 9.0 3.2
Clinical symptom (%)
Breathing difficulties 5.5 0.0
Cough 14.4 4.3
Fever 30.8 8.7
Pneumonia
(chest X-ray)
1.4 4.3
Myalgia 2.7 0.0
Sore throat 0.7 0.
Vomiting 3.4 0.0
Muscle spasm 0.7 0.0
Herpes angina 10.3 0.0
Headache 0.0 0.0
Encephalitis 0.7 0.0
a Negative for real-time reverse transcriptase polymerase chain re
H3N2, and influenza B viruses.
b Two patients co-infected with HCoV NL63 and influenza A/H1N1 a
c p < 0.02 (negative or Flu A/H1N1 positive vs. Flu A/H3N2 positive
Flu Z influenza; HCoV Z human coronavirus.
Please cite this article in press as: Huang S-H, et al., Epidemiology of h
pneumonia in Taiwan, Journal of Microbiology, Immunology and Infect(44.44%), and sore throat (11.8%), which were similar to
those of influenza A/H1N1 infection. However, co-infected
patients presented with a significantly higher incidence of
breathing difficulties (66.7%), cough (100%), and sore throat
(33.3%). By contrast, the average ages of the influenza A/
H1N1 (3.2 years) and B (23 years) positive groups among
outpatients were lower than those among hospitalized pa-
tients (Tables 1 and 2). In addition, signs and symptoms
were infrequently observed in outpatients. The results
indicated no significant differences in clinical features be-
tween HCoV-NL63 and influenza infections, but co-infection
of HCoV-NL63 and influenza A/H1N1 could cause more se-
vere symptoms than single viral infection.
Phylogenetic tree analysis of HCoV-NL63 Taiwan
isolates
For confirming HCoV-NL63 infection, the nucleotide se-
quences of 1a genes from Taiwan isolates were amplified by
RT-PCR, sequenced, and then used to analyze a phyloge-
netic relationship with worldwide strains (Figure 3). ML
analysis constructed a phylogenetic tree based on 1a gene
nucleotide sequences of 39 global strains as references and
four Taiwan isolates identified in the study. ML analysis of
HCoV-NL63 viruses distinguished two clusters, and indi-
cated that Taiwan isolates had a genetically similarity to
Cluster I, and formed a monophyletic clade with statistical
significance (bootstrap > 60%).
Discussion
This study showed the prevalence of HCoV-NL63 infection in
Taiwan during 2010e2011, after the 2009 H1N1 influenzaess in this study
ents with influenza-like illness
1 Flu A/H3N2
positive
Flu B
positive
HCoV NL63
positive/Flu A/H1N1 positiveb
5 1 0
52.0 23.0
20.0c 0.0
20.0 0.0
80.0c 0.0
40.0c 0.0
40.0c 0.0
20.0c 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
action detection of HCoV NL63, influenza A/H1N1, influenza A/
nd one co-infected with HCoV NL63 and influenza A/H3N2.
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Figure 2. Seasonal prevalence of HCoV-NL63, influenza A/H1N1, A/H3N2, and B viruses during 2010e2011 in Taiwan. Positive
numbers (left) and percentage (right) of HCoV-NL63 infection in hospitalized patients (A), as well as influenza A/B infection in
hospitalized patients (B) and outpatients (C). HCoV Z human coronavirus.
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Figure 3. Phylogenetic tree of partial 1a gene sequences from Taiwan and global HCoV-NL63 strains using maximum-likehood
method. Phylogenetic tree plots nucleotide sequences of HCoV-NL63 strains in this study and worldwide strains. Sequences
were aligned via BioEdit and Clustal_X, phylograms generated by ML methods and MEGA tree-drawing software. Branch labels
represent stability of branches >1000 bootstrap replicates, only bootstrap values > 60% are presented. HCoV Z human
coronavirus.
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for HCoV-NL63 detection were 8.4% in hospitalized patients
with pneumonia, but not found in outpatients with
influenza-like illness (Tables 1 and 2). Phylogenetic analysis
of Taiwan and global strains based on 1a gene revealed two
clusters of HCoV-NL63 viruses (Figure 3), with similar pat-
terns to previous studies.5,8 There was no difference in age-
specific distribution between HCoV-NL63 and influenza
AH1N1 infections in hospitalized patients (Figure 1). How-
ever, the age distribution patterns of HCoV-NL63 infection
in hospitalized patients differed from those of influenza A/
H3N2 and B infections in hospitalized patients and out-
patients (Tables 1 and 2). The results differed from previous
reports of low prevalence of HCoV-NL63 infection in chil-
dren, such as 1.2% in Japan,7 1.3% in Taiwan,8 2.1% in
Australia,4 2.3% in Belgium,9 2.5% in Canada,10 and 7% in
Switzerland.11 Recently, the positive rate of HCoV NL63 in a
healthy control group (8.5%) was higher than in patients
with upper respiratory tract infection (5.1%) in Ghana.16
The study was the first with a high risk of HCoV-NL63
infection in hospitalized patients with pneumonia. The
present study also identified three inpatients aged
>40 years co-infected with HCoV-NL63 and influenza A
virus. Co-infection caused significantly higher rates of
breathing difficulties, cough, and sore throat than single
infection with HCoV-NL63 and influenza A/H1N1 caused.Please cite this article in press as: Huang S-H, et al., Epidemiology of h
pneumonia in Taiwan, Journal of Microbiology, Immunology and InfectTherefore, HCoV-NL63 infection could have a considerable
impact on public health.
The study showed the seasonality of HCoV-NL63 infec-
tion as late winter, overlapping the second peak of influ-
enza epidemic in Taiwan (Figure 2). The seasonality of
HCoV-NL63 infection in Taiwan during 2010e2011 was
similar to that in temperate countries,6,7,9,10,12 but
different from some studies in which it was in autumn in
Taiwan during 2004e2005,8 summer and autumn in
Chongqing,17 and summer in Hong Kong.5 Clinical manifes-
tation analysis indicated fever (88.88%), cough (77.78%),
and pneumonia (100%), but no significant association with
the group with HCoV-NL63 infection compared to influenza
A positive groups among hospitalized patients (Table 1). In
France, a survey of patients younger than 20 years indi-
cated that more than one-third of the patients infected by
HCoV-NL63 had bronchiolitis and pneumonia.12 In Brazil, a
46-year-old female patient with HCoV-NL63 infection had
hemorrhagic pneumonia, respiratory and renal failure, and
died.18 Thus, our results demonstrated HCoV-NL63 infection
correlating with severe lower respiratory tract diseases in
adults, implying HCoV-NL63 infection as a higher risk factor
of severe respiratory illness for adults than children.
In summary, real-time RT-PCR assay identified the
overall positive rate of HCoV-NL63 infection as 8.4% in
hospitalized patients with pneumonia in Taiwan duringuman coronavirus NL63 infection among hospitalized patients with
ion (2015), http://dx.doi.org/10.1016/j.jmii.2015.10.008
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+ MODEL2010e2011. The proportion of HCoV-NL63 infection in each
age-specific group indicated HCoV-NL63 as a high risk factor
for pneumonia patients aged 16e25 years and 26e35 years.
Prevalence of HCoV-NL63 was predominant in late winter;
co-infection with HCoV-NL63 and influenza A/H1N1 was
associated with pneumonia in older adults. Phylogenetic
analysis indicated HCoV-NL63 strains in Taiwan were in one
of two major clusters based on 1a gene sequences of global
strains, showing a low level of heterogeneity between
Taiwan and global strains. Transmission of HCoV-NL63 in
older adults causes severe low respiratory tract diseases.
Our results yield a better understanding of the epidemi-
ology of HCoV-NL63 in Taiwan and contribute information
necessary for worldwide surveillance of HCoV-NL63
infection.
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